Interius BioTherapeutics to Present In Vivo CAR Data in Oncology and Autoimmunity Programs at the American Society of Gene and Cell Therapy 27th Annual Meeting

In vivo creation of autologous CAR cells after a single intravenous administration of an off-the-shelf targeted vector and formal GLP toxicology data support clinical entry in 2024 Company to deliver 3 oral and 3 poster presentations highlighting its portfolio of in vivo CAR data in…